Healthcare provider profile · identity verified

Randy K. Brown, MD

Allopathic & Osteopathic Physicians|Family Medicine · MUNCIE, IN · NPI 1629067202

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Randy K. Brown, MD received $14.23 in general payments during 2025 across 1 reported records.

ABBVIE INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Creon by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Synthroid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$14.23

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$14.23	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$14.23	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$14.23	1	2025
Source payment records 2025-09-24 · ABBVIE INC. · $14.23 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$14.23	1	2025
Source payment records 2025-09-24 · ABBVIE INC. · $14.23 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	CREON open payments reported associated product	CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608	Creon · 2024 Exact normalized brand match · 1 Part D row	16	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	24	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	772	217
Gabapentin	Gabapentin	692	123
Albuterol Sulfate Hfa	Albuterol Sulfate	475	114
Amlodipine Besylate	Amlodipine Besylate	399	101
Lisinopril	Lisinopril	379	91
Omeprazole	Omeprazole	358	88
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	357	59
Levothyroxine Sodium	Levothyroxine Sodium	340	78
Pantoprazole Sodium	Pantoprazole Sodium	268	73
Losartan Potassium	Losartan Potassium	265	67
Metformin Hcl	Metformin Hcl	258	69
Furosemide	Furosemide	236	56
Duloxetine Hcl	Duloxetine Hcl	226	46
Tamsulosin Hcl	Tamsulosin Hcl	206	47
Metoprolol Succinate	Metoprolol Succinate	200	61
Hydrochlorothiazide	Hydrochlorothiazide	194	61
Trazodone Hcl	Trazodone Hcl	191	44
Metoprolol Tartrate	Metoprolol Tartrate	187	54
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	176	42
Potassium Chloride	Potassium Chloride	168	41
Fluticasone Propionate	Fluticasone Propionate	162	52
Eliquis	Apixaban	161	30
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	157	15
Clopidogrel	Clopidogrel Bisulfate	142	36
Hydroxyzine Hcl	Hydroxyzine Hcl	141	30
Ondansetron Odt	Ondansetron	137	24
Sertraline Hcl	Sertraline Hcl	133	25
Ozempic	Semaglutide	131	27
Ropinirole Hcl	Ropinirole Hcl	126	24
Buspirone Hcl	Buspirone Hcl	118	33
Escitalopram Oxalate	Escitalopram Oxalate	114	34
Ibuprofen	Ibuprofen	112	29
Pregabalin	Pregabalin	111	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	109	34
Clonazepam	Clonazepam	101	16
Allopurinol	Allopurinol	96	28
Trulicity	Dulaglutide	93	18
Glipizide	Glipizide	88	19
Famotidine	Famotidine	82	24
Montelukast Sodium	Montelukast Sodium	81	24
Pravastatin Sodium	Pravastatin Sodium	79	21
Tizanidine Hcl	Tizanidine Hcl	79	13
Carvedilol	Carvedilol	75	23
Citalopram Hbr	Citalopram Hydrobromide	75	14
Promethazine Hcl	Promethazine Hcl	73	11
Tramadol Hcl	Tramadol Hcl	71	20
Bupropion Xl	Bupropion Hcl	68	14
Ventolin Hfa	Albuterol Sulfate	68	23
Breo Ellipta	Fluticasone/Vilanterol	64	16
Diclofenac Sodium	Diclofenac Sodium	62	17
Jardiance	Empagliflozin	60	17
Methocarbamol	Methocarbamol	60	14
Symbicort	Budesonide/Formoterol Fumarate	60	19
Fenofibrate	Fenofibrate	59	14
Nystatin	Nystatin	59	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	11
Rosuvastatin Calcium	Rosuvastatin Calcium	58	16
Azelastine Hcl	Azelastine Hcl	57	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	14
Alprazolam	Alprazolam	56	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	32
Clonidine Hcl	Clonidine Hcl	55	14
Azithromycin	Azithromycin	53	37
Doxycycline Hyclate	Doxycycline Hyclate	50	34
Mirtazapine	Mirtazapine	50	12
Metformin Hcl Er	Metformin Hcl	49	15
Triamcinolone Acetonide	Triamcinolone Acetonide	49	30
Meloxicam	Meloxicam	47	13
Ondansetron Hcl	Ondansetron Hcl	47	suppressed
Rybelsus	Semaglutide	46	11
Sumatriptan Succinate	Sumatriptan Succinate	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	45	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	45	12
Spironolactone	Spironolactone	45	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	45	38
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Ezetimibe	Ezetimibe	44	16
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Spiriva Respimat	Tiotropium Bromide	44	suppressed
Prednisone	Prednisone	43	22
Aripiprazole	Aripiprazole	42	13
Humalog Kwikpen U-100	Insulin Lispro	42	12
Levetiracetam	Levetiracetam	42	suppressed
Topiramate	Topiramate	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Mupirocin	Mupirocin	39	26
Nitroglycerin	Nitroglycerin	39	20
Amitriptyline Hcl	Amitriptyline Hcl	38	11
Naproxen	Naproxen	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Primidone	Primidone	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Cephalexin	Cephalexin	35	23
Enalapril Maleate	Enalapril Maleate	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Mounjaro	Tirzepatide	34	suppressed
Torsemide	Torsemide	34	11
Esomeprazole Magnesium	Esomeprazole Magnesium	33	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	33	11
Simvastatin	Simvastatin	33	suppressed
Baclofen	Baclofen	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Trintellix	Vortioxetine Hydrobromide	31	suppressed
Diazepam	Diazepam	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Ketoconazole	Ketoconazole	29	12
Meclizine Hcl	Meclizine Hcl	29	13
Varenicline Tartrate	Varenicline Tartrate	29	suppressed
Fluconazole	Fluconazole	28	13
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Oxcarbazepine	Oxcarbazepine	26	suppressed
Amoxicillin	Amoxicillin	25	15
Lidocaine	Lidocaine	25	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Loperamide	Loperamide Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Spiriva Handihaler	Tiotropium Bromide	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	12
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Nurtec Odt	Rimegepant Sulfate	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Creon	Lipase/Protease/Amylase	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Colchicine	Colchicine	15	suppressed
Dexilant	Dexlansoprazole	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Niacin Er	Niacin	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Halobetasol Propionate	Halobetasol Propionate	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Savella	Milnacipran Hcl	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Aptiom	Eslicarbazepine Acetate	12	suppressed
Austedo	Deutetrabenazine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	11	suppressed
Estradiol	Estradiol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Nystop	Nystatin	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$14.23 · 1 records	ABBVIE INC.	QULIPTA, UBRELVY	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error